- Clinical artificial intelligence company Sensyne Health made a positive debut on AIM after raising £60m through an initial public offering.

Early on Friday, shares in the company were trading at 185p each, up 5.7% on their IPO price of 175p.

'The strong support from institutional investors for our IPO will enable us to grow our team of highly-skilled clinicians, data scientists and software developers to use the power of clinical AI to improve patient care and accelerate the development of new medicines,' chief executive Lord Paul Drayson said.

'Our evolution into a public company has already stimulated further business development interest in our work and we are delighted to begin life as a plc on the London Stock Exchange.'

At 8:32am: [LON:SENS] share price was +187.5p at 187.5p

Story provided by